Efficacy of pregabalin, amitriptyline, and gabapentin for neuropathic pain
- PMID: 38854766
- PMCID: PMC11161879
- DOI: 10.6026/973206300200386
Efficacy of pregabalin, amitriptyline, and gabapentin for neuropathic pain
Abstract
Neuropathic pain largely influences the well-being of patients. Anticonvulsant and antidepressant medications, such as Pregabalin, Gabapentin, and Amitriptyline, are routinely prescribed as initial treatments for neuropathic pain. The study sample has a total of 270 patients who meet the inclusion criteria and are further distributed into three equally sized groups (A, B, and C). Group A was administered with Gabapentine 300mg, Group B with Pregabalin 75 mg, and Amitriptyline 10 mg to Group C. The occurrence of any adverse drug response was documented using the ADR reporting form, while the pain of the patient's post-medication was recorded using a numerical pain rating scale (NPRS). The comparison of the NPRS scores of all three groups "by using ANOVA test" both at baseline and after 15 days reveal that the differences between the three groups are statistically insignificant (p > 0.089). However, after one month of continuous use, the difference becomes slightly significant (I.e., p = 0.003). Gabapentin, pregabalin, and amitriptyline demonstrate similar effectiveness in alleviating neuropathic (NeP) pain. The study concludes that gabapentin is superior to both pregabalin and amitriptyline with fewer adverse effects, leading to improved patient adherence for long-term use.
Keywords: Nerve pain; anxiety; depression; gabapentin; pregabalin; spinal cord injuries.
© 2024 Biomedical Informatics.
Similar articles
-
Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.Health Technol Assess. 2022 Oct;26(39):1-100. doi: 10.3310/RXUO6757. Health Technol Assess. 2022. PMID: 36259684 Free PMC article. Clinical Trial.
-
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.Lancet. 2022 Aug 27;400(10353):680-690. doi: 10.1016/S0140-6736(22)01472-6. Epub 2022 Aug 22. Lancet. 2022. PMID: 36007534 Free PMC article. Clinical Trial.
-
Antiepileptic drugs for chronic non-cancer pain in children and adolescents.Cochrane Database Syst Rev. 2017 Aug 5;8(8):CD012536. doi: 10.1002/14651858.CD012536.pub2. Cochrane Database Syst Rev. 2017. PMID: 28779491 Free PMC article. Review.
-
Nortriptyline for neuropathic pain in adults.Cochrane Database Syst Rev. 2015 Jan 8;1(1):CD011209. doi: 10.1002/14651858.CD011209.pub2. Cochrane Database Syst Rev. 2015. PMID: 25569864 Free PMC article. Review.
-
Drug Class Review: Neuropathic Pain: Final Update 1 Report [Internet].Portland (OR): Oregon Health & Science University; 2011 Jun. Portland (OR): Oregon Health & Science University; 2011 Jun. PMID: 21977547 Free Books & Documents. Review.
References
LinkOut - more resources
Full Text Sources
Research Materials